SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ACADIA Pharmaceuticals Inc (ACAD)
An SI Board Since April 2004
Posts SubjectMarks Bans Symbol
588 32 0 ACAD
Emcee:  michael_f_murphy Type:  Unmoderated
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
13ACADIA Study Links ACP-104 (N-desmethylclozapine) to Improved Cognition in Schizmopgcw-8/3/2004
12Piper pt 2: SCHIZOPHRENIA Schizophrenia is a chronic and disabling mental mopgcw-7/12/2004
11Piper: July 12, 2004 ACADIA Pharmaceuticals Outperform Volatility: Higmopgcw-7/12/2004
10ACADIA Pharmaceuticals Presents Favorable Results From Phase Ib/ 2004-06-29 09:0mopgcw-6/29/2004
9Acadia Pharmaceuticals Raises $35 Mln in Initial Stock Offering 2004-05-26 18:0mopgcw-6/23/2004
8ACADIA Pharmaceuticals Completes $25 Million Private Placement 2003-03-28 08:00mopgcw-6/23/2004
7ACADIA Expands Pain Portfolio to Include New GPCR Targets Discovery of First Smmopgcw-6/23/2004
6ACADIA Discovers Novel Small Molecule Leads for the V2 Vasopressin Receptor Chemopgcw-6/23/2004
5ACADIA Applies Chemical Genomics to Discover Small Molecule Leads For Numerous Gmopgcw-6/23/2004
4ACADIA Reports on Second Innovative Approach to Drug Treatment of Psychosis; Novmopgcw-6/23/2004
3ACADIA Nominates 5-HT2A Inverse Agonist for Clinical Development in Psychosis; Cmopgcw-6/23/2004
2Past attempt to IPO...ACADIA Pharma withdraws its IPO 2001-09-04 09:05 (New Yormopgcw-6/23/2004
1ACADIA Identifies Novel Muscarinic Mechanism for Treatment of Chronic Pain 200mopgcw-6/23/2004
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):